AirSculpt Technologies (AIRS)
Provides private-pay body-contouring procedures through AirSculpt centers in the U.S. and Canada.
AirSculpt Sees Core Stabilization, Targets $100M-Plus GLP-1 Opportunity
AirSculpt Technologies NASDAQ: AIRS is seeing stabilization in its core body-contouring business after several quarters of declines, while expanding services aimed at patients using GLP-1 weight-loss drugs, Chief Executive Officer Yogi Jashnani said at a Canaccord consumer conference.
AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call Transcript
AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call Transcript
AirSculpt Technologies Q2 Earnings Call Highlights
AirSculpt Technologies NASDAQ: AIRS reported second-quarter revenue of $42.9 million, down 2.5% from the prior-year period, as the company cited stable revenue trends, positive same-center case growth and continued investment in marketing and expanded procedure offerings.
Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Monday.
AirSculpt Technologies Reports Second Quarter Fiscal 2026 Results
MIAMI BEACH, Fla., Aug. 10, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the second quarter ended June 30, 2026.
AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Second Quarter Fiscal 2026 Results
Company to Participate in Canaccord Genuity's 46th Annual Growth Conference Company to Participate in Canaccord Genuity's 46th Annual Growth Conference
AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions
HONG KONG & SEOUL, South Korea--(BUSINESS WIRE)--AIRS Medical (“the Company”), a global leader in AI solutions for medical imaging, today announced a strategic growth investment from TA Associates (“TA”), a leading global private equity firm. The investment will help fuel AIRS Medical's next phase of global expansion, advancement of its AI-powered radiology technology solutions and ongoing product innovation. Founded in 2018, AIRS Medical develops AI-native magnetic resonance imaging (“MRI”) ac.
Is Prisma AIRS Becoming Palo Alto Networks' Fastest Growth Engine?
Palo Alto Networks is seeing rapid adoption of Prisma AIRS, with customer growth and larger AI security deals boosting its revenue potential.
AirSculpt Technologies Announces Participation in Upcoming Investor Conferences
MIAMI BEACH, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, today announced that the Company will participate in upcoming investor conferences.
AirSculpt Technologies Sees Sales Rebound, GLP-1 Tailwind for Body Contouring Growth
AirSculpt Technologies NASDAQ: AIRS executives said the body contouring company has returned to same-store sales growth after more than two years of declines, while outlining plans to expand services tied to GLP-1 weight-loss drug side effects and eventually resume clinic growth across the U.S.
AirSculpt Technologies, Inc. (AIRS) Shareholder/Analyst Call Prepared Remarks Transcript
AirSculpt Technologies, Inc. (AIRS) Shareholder/Analyst Call Prepared Remarks Transcript
AirSculpt Technologies Q1 Earnings Call Highlights
AirSculpt Technologies NASDAQ: AIRS reported first-quarter fiscal 2026 results that management characterized as a “key turning point,” citing stabilized revenue, the first positive same-center sales result in more than two years, and continued debt reduction. Get AirSculpt Technologies alerts:Sign UpQ1 results: flat revenue, positive same-center sales, and margin expansion Chief Executive Officer Yogi Jashnani said the company “stabilized revenue year-over-year and delivered positive same-center sales for the first time in over two years,” while also expanding gross margin.
AirSculpt Technologies, Inc. (AIRS) Q1 2026 Earnings Call Transcript
AirSculpt Technologies, Inc. (AIRS) Q1 2026 Earnings Call Transcript
AirSculpt Technologies Reports First Quarter Fiscal 2026 Results
MIAMI BEACH, Fla. , May 08, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ: AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2026. Yogi Jashnani, Chief Executive Officer, stated: "We had a solid start to the year delivering stabilization in revenue, positive same center sales, and a strengthened balance sheet in the first quarter.
AirSculpt Technologies Reports First Quarter Fiscal 2026 Results
MIAMI BEACH, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2026.
AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results
MIAMI BEACH, Fla., May 01, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report first quarter 2026 financial results before market open on Friday, May 8, 2026, to be followed by a conference call on the same day at 8:30 a.m.
CORRECTION -- AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results
MIAMI BEACH, Fla., April 06, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 2nd, 2026, by AirSculpt Technologies, Inc. (NASDAQ:AIRS), please note that the Company determined that a one-time non-cash adjustment related to the closure of its London facility was inaccurate in the calculation of Adjusted EBITDA, Adjusted EBITDA Margin, and Adjusted Net (Loss)/Income. The updated release reflects the updated figures.
Critical Contrast: AirSculpt Technologies (NASDAQ:AIRS) & Bit Digital (NASDAQ:BTBT)
Bit Digital (NASDAQ: BTBT - Get Free Report) and AirSculpt Technologies (NASDAQ: AIRS - Get Free Report) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Institutional and Insider Ownership 47.7% of
AirSculpt Technologies Q4 Earnings Call Highlights
AirSculpt Technologies (NASDAQ: AIRS) reported fourth-quarter and full-year 2025 results while outlining initiatives management said have stabilized the business and returned same-store sales to growth entering fiscal 2026. On the company's earnings call, Chief Executive Officer Yogi Jashnani said same-store sales trends improved sequentially over the course of 2025, "inflected to positive same-store sales growth" beginning
AirSculpt Technologies, Inc. (AIRS) Q4 2025 Earnings Call Transcript
AirSculpt Technologies, Inc. (AIRS) Q4 2025 Earnings Call Transcript